ONYX — Onyx Biotec Balance Sheet
0.000.00%
- IN₹706.25m
- IN₹744.71m
- IN₹619.51m
- 56
- 52
- 16
- 33
Annual balance sheet for Onyx Biotec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.136 | 0.074 | 14.7 | 86.1 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 110 | 53.2 | 156 | 204 |
| Total Inventory | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 144 | 146 | 296 | 492 |
| Net Property, Plant And Equipment | 213 | 425 | 435 | 409 |
| Other Long Term Assets | ||||
| Total Assets | 368 | 587 | 741 | 912 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 100 | 202 | 226 | 257 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 205 | 405 | 493 | 356 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 164 | 182 | 249 | 556 |
| Total Liabilities & Shareholders' Equity | 368 | 587 | 741 | 912 |
| Total Common Shares Outstanding |